Kymera Appoints Felix Baker as Board Chairman

RTTNews··Read original
2▲0 ▼0Impact / 5
Summary · why it matters

Kymera Therapeutics has appointed Felix J. Baker as Chairman of the Board of Directors, succeeding Bruce Booth. Baker previously served as the company's Lead Independent Director since 2024 and is a Managing Member of Baker Brothers Investment. Booth, who had been Chairman since 2016, will remain on the Board as an Independent Director. Kymera shares closed Wednesday at $99.87, up 1.65%, and rose a further 0.33% in after-hours trading to $100.20.

Impact on assets 5

Biotech & Genomic Medicine▲ · 2 stocks
Kymera Therapeutics Inc
KYMR
± MixedCapitalrelevance

Appointment of Felix Baker as Chairman, a board governance change with no clear directional impact on operations or strategy.

Health Care▲ · 1 stocks
Aging Population▲ · 1 stocks
Others▲ · 1 stocks
© 2026 MarketIVNews